ConductScience.org, home

Gene · 283149

BCL9L: BCL9 like

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. BCL9L: BCL9 like. Genes, record 283149. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/283149

On this page

Gene

Symbol
BCL9L
HGNC
Name
BCL9 like
HGNC
NCBI Gene ID
283149
NCBI Gene
HGNC ID
HGNC:23688
HGNC
Ensembl
ENSG00000186174
NCBI Gene
Aliases
B9L, BCL9-2, Bcl9-2, DLNB11
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q86UU0B-cell CLL/lymphoma 9-like protein1,4993Ensembl, GeneID, HGNC

Source UniProt

Patents15

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1438674Q86UU0Espacenet
EP 4650780 A22025-11-196169Q86UU0Espacenet
EP 4641201 A22025-10-295917Q86UU0Espacenet
EP 4641202 A22025-10-295076Q86UU0Espacenet
JP 2025517969 A2025-06-125917Q86UU0Espacenet
JP 2025517970 A2025-06-126169Q86UU0Espacenet
JP 2025062604 A2025-04-148477Q86UU0Espacenet
KR 1020250017231 A2025-02-045076Q86UU0Espacenet
US 11446398 B22022-09-208477Q86UU0Espacenet
JP 2022524081 A2022-04-27111448Q86UU0Espacenet

1 to 10 of 15

See all 15 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants358

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleBCL9L papersNewest fiscal year
P30CA016672Cancer Center Support Grant32025
P30CA076292Moffitt Cancer Center Support Grant22025
P30CA093373Cancer Center Support Grant P3022025
P30ES017885Michigan Center on Lifestage Environmental Exposures and Disease (M-LEEaD)22025
IK6BX004855BLR&D Research Career Scientist Award Application12025
K12HD000849Reproductive Scientist Development Program12025
P01CA155258Integrative Oncogenomics of Multiple Myeloma12025
P20GM103418Kansas IDeA Network of Biomedical Research Excellence 512025
P20GM103434West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE)12025
P20GM103446Delaware INBRE12025

1 to 10 of 358Source NIH's project files

See all 358 nih grants

Papers451

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Mutant KRAS-m6A Epitranscriptome Axis Promotes Colorectal Cancer and is a Therapeutic Target.Adv Sci (Weinh)202642717493PubTator, text miningPubMed
Association of chemokine and chemokine receptor gene variants with occurrence of multiple primary melanoma.Melanoma Res202642550086PubTator, text miningPubMed
Targeting BCL9/BCL9L enhances CD4+ T cell-mediated Th1 antitumor immunity through activation of STAT1/STAT4 signaling.Acta Pharmacol Sin202642366227PubTator, text miningPubMed
ZW4864-mediated inhibition of the β-catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer.Mol Oncol202642316797PubTator, text miningPubMed
The Molecular Landscape of CASTLE: A Rare Thymus-like Head and Neck Cancer.Int J Mol Sci202642074143PubTator, text miningPubMed
Impact of Copy Number Alterations on Human Papillomavirus (HPV)-Induced and HPV-Independent Penile Cancers.Lab Invest202642031074PubTator, text miningPubMed
CD44/POU2F2/BCL9L axis mediates MIF-driven SPP1+TAM activation in colorectal cancer metastasis.Int J Biol Sci202641800265PubTator, text miningPubMed
Circular RNA hsa_circ_0006168: A potential biomarker for the diagnosis and prognosis of prostate cancer.Oncol Lett202641560974PubTator, text miningPubMed
Abnormal expression of miR-136-5p in glioma cancer patients and its correlation with CT signs.Neurol Res202640717514PubTator, text miningPubMed
Identification of immunometabolism-associated genes and immune infiltration in sepsis-induced cardiomyopathy using integrated bioinformatics and machine learning approaches.J Int Med Res202541254473PubTator, text miningPubMed

1 to 10 of 451

See all 451 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/283149

GET https://conductscience.org/api/genes/v1/283149/patents